CCT Banner

 

CerecyteMicrus Cerecyte Registry

  • A registry to evaluate outcomes at one year post-mmbolization with the Micrus Cerecyte Microcoil System.

Hypothesis:

  • Aneurysms treated with CERECYTE coils will demonstrate effective long-term angiographic occlusion and a patent parent artery at 12-19 months

Objective:

  • To evaluate the clinical and angiographic outcomes of intracranial aneurysm embolization using the Micrus Cerecyte Microcoil System

Study Design:

  • Prospective, single arm, multi-center registry
  • Non-experimental: Assessments based on standard-of-care
  • Designed to document the immediate and long-term (12-19 month) angiographic outcomes using modified Raymond-Roy grading scale (RRGS)
  • Angiograms assessed by an independent Core Lab


Cerecyte

Enrollment Progress:

  • 250 Patients enrolled from 15 US centers
  • An interim analysis is currently being prepared to submit for publication

Current Sites

Globe

Contact Information

If you would like more information about the Cerecyte Registry, please feel free to contact us:

Meg Guilhermier
Director of Clinical Research
mguilhermier@micruscorp.com